Coronary revascularization in diabetic patients: Current state of evidence

Experimental and Clinical Cardiology

Volumn 16, Issue 1, 2011, Pages 16-22

  Singh, Mukesh ^a   Arora, Rohit ^a   Kodumuri, Vamsi ^a   Khosla, Sandeep ^a   Jawad, Evyan ^a  

^a ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

Author keywords

CABG; Coronary revascularization; Diabetes mellitus; PCI

Indexed keywords

ABCIXIMAB; ANTITHROMBOCYTIC AGENT; INSULIN; RAPAMYCIN;

BARE METAL STENT; BLOOD CLOT LYSIS; CLINICAL DECISION MAKING; CONGESTIVE HEART FAILURE; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY STENT; DIABETES MELLITUS; DIABETIC PATIENT; DRUG ELUTING STENT; FOLLOW UP; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE REVASCULARIZATION; HEART VENTRICLE SEPTUM RUPTURE; HUMAN; INSULIN TREATMENT; INTERMETHOD COMPARISON; ISCHEMIC HEART DISEASE; KIDNEY DYSFUNCTION; KIDNEY FAILURE; MEDIASTINITIS; MORTALITY; MYOCARDIAL DISEASE; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PROGNOSIS; REVIEW; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STROKE; SURVIVAL RATE; SURVIVAL TIME; TRANSLUMINAL CORONARY ANGIOPLASTY; VASCULAR PATENCY; WOUND INFECTION;

EID: 79953823506     PISSN: 12056626     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (100)

1. Hammound T, Tanguay JF, Bourassa MG. Management of coronary artery disease: Therapeutic options in patients with diabetes. J Am Coll Cardiol 2000;36:355-65. (Pubitemid 30627410)
2. Choi D, Kim SK, Choi SH, et al. Preventative effects of rosiglitazone on restenosis after coronary stent implantation in patients with type 2 diabetes. Diabetes Care 2004;27:2654.
3. Kastrati A, Mehilli J, Schuhlen H, et al. A clinical trial of abciximab in elective percutaneous coronary intervention after pretreatment with clopidogrel. N Engl J Med 2004;350:232.
4. Schomig A, Schmitt C, Dibra A, et al. One year outcomes with abciximab vs. placebo during percutaneous coronary intervention after pre-treatment with clopidogrel. Eur Heart J 2005;26:1379.
5. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-97..
6. Frye RL, August P, Brooks MM, et al. A randomized trial of therapies for type 2 diabetes and coronary artery disease. N Engl J Med 2009;360:2503.
7. Seidell JC. Obesity, insulin resistance and diabetes - a worldwide epidemic. Br J Nutr 2000;83(Suppl 1):S5-S8. (Pubitemid 30319075)
8. Kopelman PG, Hitman GA. Diabetes. Exploding type II. Lancet 1998;352(Suppl 4):SIV5.
9. Cook S, Scherrer U. Insulin resistance, a new target for nitric oxide-delivery drugs. Fundam Clin Pharmacol 2002;16:441-53. (Pubitemid 35463880)
10. Amos AF, McCarty DJ, Zimmet P. The rising global burden of diabetes and its complications: Estimates and projections to the year 2010. Diabet Med 1997;14(Suppl 5):S1-S85.
11. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995 to 2025: Prevalence, numerical estimates, and projections. Diabetes Care 1998;21:1414-31.
12. Krolewski AS, Kosinski EJ, Warram JH, et al. Magnitude and determinants of coronary artery disease in juvenile-onset, insulin-dependent diabetes mellitus. Am J Cardiol 1987;59:750-5. (Pubitemid 17061281)
13. Krolewski AS, Warram JH, Rand LI, Kahn CR. Epidemiologic approach to the etiology of type I diabetes mellitus and its complications. N Engl J Med 1987;317:1390-8. (Pubitemid 18052346)
14. Waller BF, Palumbo PJ, Lie JT, Roberts WC. Status of the coronary arteries at necropsy in diabetes mellitus with onset after age 30 years. Analysis of 229 diabetic patients with and without clinical evidence of coronary heart disease and comparison to 183 control subjects. Am J Med 1980;69:498-506. (Pubitemid 10018704)
15. Lee WL, Cheung AM, Cape D, Zinman B. Impact of diabetes on coronary artery disease in women and men: A meta-analysis of prospective studies. Diabetes Care 2000;23:962-8. (Pubitemid 30480024)
16. McGovern PG, Pankow JS, Shahar E, et al. Recent trends in acute coronary heart disease - mortality, morbidity, medical care, and risk factors. The Minnesota Heart Survey Investigators. N Eng J Med 1996;334:884-90. (Pubitemid 26107346)
17. Centers for Disease Control and Prevention. Trends in ischemic heart disease deaths - United States 1990-1994. JAMA 1997;277:1109.
18. Tunstall-Pedoe H, Vanuzzo D, Hobbs M, et al. Estimation of contribution of changes in coronary care to improving survival, event rates, and coronary heart disease mortality across the WHO MONICA Project populations. Lancet 2000;335:688-700. (Pubitemid 30107624)
19. McGovern PG, Jacobs DR Jr, Shahar E, et al. Trends in acute coronary heart disease mortality, morbidity, and medical care from 1985 through 1997: The Minnesota Heart Survey. 2001;104:19-24.
20. Fox K, Mehta S, Peters R, et al. Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: The Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial. Circulation 2004;110:1202-8. (Pubitemid 39202333)
21. Unal B, Critchley JA, Capewell S. Explaining the decline in coronary heart disease mortality in England and Wales between 1981 and 2000. Circulation 2004;109:1101-7.
22. Lorenz DP, Carrozza JP, Garcia L. Diabetes and percutaneous interventional therapy. In: Johnstone MT, Veves A, eds. Diabetes and Cardiovascular Disease, 2nd edn. Totowa: Humana Press, 2005.
23. Tanveer A, Khan PV, Sellke FW. Cardiac surgery and diabetes mellitus. In: Johnstone MT, Veves A, eds. Diabetes and Cardiovascular Disease, 2nd edn. Totowa: Humana Press, 2005.
24. Van Belle E, Périé M, Braune D, et al. Effects of coronary stenting on vessel patency and long-term clinical outcome after percutaneous coronary revascularization in diabetic patients. J Am Coll Cardiol 2002;40:410-7. (Pubitemid 34833153)
25. Influence of diabetes on 5-year mortality and morbidity in a randomized trial comparing CABG and PTCA in patients with multivessel disease: The Bypass Angioplasty Revascularization Investigation (BARI). Circulation 1997;96:1761-9.
26. Kip KE, Faxon DP, Detre KM, Yeh W, Kelsey SF, Currier JW. Coronary angioplasty in diabetic patients. The National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry. Circulation 1996;94:1818-25. (Comment in 1996;94:1804-6).
27. Flaherty JD, Davidson CJ. Diabetes and coronary revascularization. JAMA 2005;293:1501-8. (Pubitemid 40393296)
28. Stein B, Weintraub WS, Gebhart SP, et al. Influence of diabetes mellitus on early and late outcome after percutaneous transluminal coronary angioplasty. Circulation 1995;91:979-89.
29. Laskey WK, Selzer F, Vlachos HA, et al. Comparison of in-hospital and one-year outcomes in patients with and without diabetes mellitus undergoing percutaneous catheter intervention (from the National Heart, Lung, and Blood Institute Dynamic Registry). Am J Cardiol 2002;90:1062-7. (Pubitemid 35335594)
30. Marso SP, Giorgi LV, Johnson WL, et al. Diabetes mellitus is associated with a shift in the temporal risk profile of inhospital death after percutaneous coronary intervention: An analysis of 25,223 patients over 20 years. Am Heart J 2003;145:270-7. (Pubitemid 36207948)
31. Smith LR, Harrell FE Jr, Rankin JS, et al. Determinants of early versus late cardiac death in patients undergoing coronary artery bypass graft surgery. Circulation 1991;84(5 Suppl):III245-53.
32. Calafiore AM, Di Mauro M, Di Giammarco G, et al. Effect of diabetes on early and late survival after isolated first coronary bypass surgery in multivessel disease. J Thorac Cardiovasc Surg 2003;125:144-54. (Pubitemid 36120281)
33. Thourani VH, Weintraub WS, Stein B, et al. Influence of diabetes mellitus on early and late outcome after coronary artery bypass grafting. Ann Thorac Surg 1999;67:1045-52. (Pubitemid 29238294)
34. Fietsam R Jr, Bassett J, Glover JL. Complications of coronary artery surgery in diabetic patients. Am Surg 1991;57:551-7.
35. Carson JL, Scholz PM, Chen AY, Peterson ED, Gold J, Schneider SH. Diabetes mellitus increases short-term mortality and morbidity in patients undergoing coronary artery bypass graft surgery. J Am Coll Cardiol 2002;40:418-23. (Pubitemid 34833154)
36. Szabo Z, Hakanson E, Svedjeholm R. Early postoperative outcome and medium-term survival in 540 diabetic and 2239 nondiabetic patients undergoing coronary artery bypass grafting. Ann Thorac Surg 2002;74:712-9. (Pubitemid 35001797)
37. Zacharias A, Habib RH. Factors predisposing to median sternotomy complications. Deep vs superficial infection. Chest 1996;110:1173-8.
38. Carpino PA, Khabbaz KR, Bojar RM, et al. Clinical benefits of endoscopic vein harvesting in patients with risk factors for saphenectomy wound infections undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg 2000;119:69-75.
39. Morricone L, Ranucci M, Denti S, et al. Diabetes and complications after cardiac surgery: Comparison with a non-diabetic population. Acta Diabetol 1999;36:77-84.
40. Bucerius J, Gummert JF, Borger MA, et al. Stroke after cardiac surgery: A risk factor analysis of 16,184 consecutive adult patients. Ann Thorac Surg 2003;75:472-8. (Pubitemid 36184491)
41. Hogue CW Jr, Murphy SF, Schechtman KB, Davila-Roman VG. Risk factors for early or delayed stroke after cardiac surgery. Circulation 1999;100:642-7. (Pubitemid 29379754)
42. Newman MF, Wolman R, Kanchuger M, et al. Multicenter preoperative stroke risk index for patients undergoing coronary artery bypass graft surgery. Multicenter Study of Perioperative Ischemia (McSPI) Research Group. Circulation 1996;94:II74-80.
43. Grayson AD, Khater M, Jackson M, Fox MA. Valvular heart operation is an independent risk factor for acute renal failure. Ann Thorac Surg 2003;75:1829-35. (Pubitemid 36677224)
44. Sharony R, Grossi EA, Saunders PC, et al. Aortic valve replacement in patients with impaired ventricular function. Ann Thorac Surg 2003;75:1808-14.
45. Rao V, Ivanov J, Weisel RD, Ikonomidis JS, Christakis GT, David TE. Predictors of low cardiac output syndrome after coronary artery bypass. J Thorac Cardiovasc Surg 1996;112:38-51. (Pubitemid 26268967)
46. Harjai KJ, Stone GW, Boura J, et al. Comparison of outcomes of diabetic and nondiabetic patients undergoing primary angioplasty for acute myocardial infarction. Am J Cardiol 2003;91:1041-5. (Pubitemid 36514916)
47. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: A quantitative review of 23 randomisned trials. Lancet 2003;361:13-20. (Pubitemid 36050955)
48. Grines C, Patel A, Zijlstra F, et al. Primary coronary angioplasty compared with intravenous thrombolytic therapy for acute myocardial infarction: Six-month follow up and analysis of individual patient data from randomized trials. Am Heart J 2003;145:47-57. (Pubitemid 36034497)
49. Timmer JR, Ottervanger JP, Thomas K, et al. Long-term, cause-specific mortality after myocardial infarction in diabetes. Eur Heart J 2004;25:926-31. (Pubitemid 38857866)
50. Montalescot G, Barragan P, Wittenberg O, et al. Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction. New Engl J Med 2001;344:1895-903. (Pubitemid 32553358)
51. Montalescot G, Antoniucci D, Kastrati A, et al. Abciximab in primary coronary stenting of ST-elevation myocardial infarction: A European meta-analysis on individual patients' data with long-term follow-up. Eur Heart J 2007;28:443-9. (Pubitemid 47343560)
52. Stuckey TD, Stone GW, Cox DA, et al. Impact of stenting and abciximab in patients with diabetes mellitus undergoing primary angioplasty in acute myocardial infarction (the CADILLAC trial). Am J Cardiol 2005;95:1-7. (Pubitemid 40051103)
53. Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol 2000;36:970-1062. (Erratum in 2001;38:294-5).
54. Hirotani T, Kameda T, Kumamoto T, Shirota S, Yamano M. Effects of coronary artery bypass grafting using internal mammary arteries for diabetic patients. J Am Coll Cardiol 1999;34:532-8.
55. Morris JJ, Smith LR, Jones RH, et al. Influence of diabetes and mammary artery grafting on survival after coronary bypass. Circulation 1991;84(5 Suppl):III275-84.
56. Farinas JM, Carrier M, Hébert Y, et al. Comparison of long-term clinical results of double versus single internal mammary artery bypass grafting. Ann Thorac Surg 1999;67:466-70. (Pubitemid 29177000)
57. Ferguson JJ. NHLI BARI clinical alert on diabetics treated with angioplasty. Circulation 1995;92:3371.
58. O'Shea JC, Buller CE, Cantor WJ, et al. Long-term efficacy of platelet glycoprotein IIb/IIIa integrin blockade with eptifibatide in coronary stent intervention. JAMA 2002;287:618-21. (Pubitemid 34252014)
59. King SB, Kosinski AS, Guyton RA, Lembo NJ, Weintraub WS. Eight-year mortality in the Emory Angioplasty versus Surgery Trial (EAST). J Am Coll Cardiol 2000;35:1116-21. (Pubitemid 30206883)
60. CABRI Trial Participants. First-year results of CABRI (coronary angioplasty versus bypass revascularisation investigation). Lancet 1995;346:1179-84.
61. The Bypass Angioplasty Revascularization Investigation (BARI) Investigators. Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. New Engl J Med 1996;335:217-25.
62. Henderson RA, Pocock SJ, Sharp SJ, et al. Long-term results of RITA-1 trial: Clinical and cost comparisons of coronary angioplasty and coronary-artery bypass grafting. Randomised intervention treatment of angina. Lancet 1998;352:1419-25. (Comment in ACP J Club 1998;130:30 and Lancet 1999;353:321).
63. Hoffman SN, TenBrook JA, Wolf MP. A meta-analysis of randomized controlled trials comparing coronary artery bypass graft with percutaneous transluminal coronary angioplasty: One- to eight-year outcomes. J Am Coll Cardiol 2003;41:1293.
64. Sedlis SP, Morrison DA, Lorin JD, et al. Percutaneous coronary intervention versus coronary bypass graft surgery for diabetic patients with unstable angina and risk factors for adverse outcomes with bypass: Outcome of diabetic patients in the AWESOME randomized trial and registry. J Am Coll Cardiol 2002;40:1555-66. (Pubitemid 35253632)
65. Serruys PW, Ong ATL, van Herwerden LA, et al. Five-year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease: The final analysis of the Arterial Revascularization Therapies Study (ARTS) randomized trial. J Am Coll Cardiol 2005;46:575-81. (Pubitemid 41132680)
66. Booth J, Clayton T, Pepper J, et al. Randomized, controlled trial of coronary artery bypass surgery versus percutaneous coronary intervention in patients with multivessel coronary artery disease: Six-year follow-up from the Stent or Surgery Trial (SoS). Circulation 2008;118:381-8.
67. Rodriguez AE, Baldi J, Pereira CF, et al. Five-year follow-up of the Argentine randomized trial of coronary angioplasty with stenting versus coronary bypass surgery in patients with multiple vessel disease (ERACI II). J Am Coll Cardiol 2005;46:582-8. (Pubitemid 41132681)
68. Hueb W, Lopes NH, Gersh BJ, et al. Five-year follow-up of the Medicine, Angioplasty, or Surgery Study (MASS II): A randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease. Circulation 2007;115:1082-9. (Pubitemid 46673170)
69. Sigwart U, Stables RH, Booth J, et al. Coronary artery bypass surgery versus percutaneous coronary intervention with stent implantation in patients with multivessel coronary artery disease (the Stent or Surgery trial): A randomised controlled trial. Lancet 2002;360:965-70. (Pubitemid 35284106)
70. Rodriguez A, Bernardi V, Navia J, et al. Argentine randomized study: Coronary angioplasty with stenting versus coronary bypass surgery in patients with multiple-vessel disease (ERACI II): 30-day and one-year follow-up results. J Am Coll Cardiol 2001;37:51-8. (Pubitemid 32051717)
71. Bravata DM, Gienger AL, McDonald KM, et al. Systematic review: The comparative effectiveness of percutaneous coronary interventions and coronary artery bypass graft surgery. Ann Intern Med 2007;147:703-16. (Pubitemid 351664467)
72. Hlatky, MA, Boothroyd, DB, Bravata, DM, et al. Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: A collaborative analysis of individual patient data from ten randomised trials. Lancet 2009;373:1190.
73. Stettler C, Wandel S, Allemann S, et al. Outcomes associated with drug-eluting and bare-metal stents: A collaborative network meta-analysis. Lancet 2007;370:937.
74. Moses JW, Leon MB, Popma JJ, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003;349:1315-23. (Pubitemid 37186209)
75. Moussa I, Leon MB, Baim DS, et al. Impact of sirolimus-eluting stents on outcome in diabetic patients: A SIRIUS (SIRolImUS-coated Bx Velocity balloon-expandable stent in the treatment of patients with de novo coronary artery lesions) substudy. Circulation 2004;109:2273-8. (Pubitemid 38678518)
76. Hermiller JB, Raizner A, Cannon L, et al. Outcomes with the polymer-based paclitaxel-eluting TAXUS stent in patients with diabetes mellitus: The TAXUS-IV trial. J Am Coll Cardiol 2005;45:1172-9. (Pubitemid 40523133)
77. Sabate M, Jimenez-Quevedo P, Angiolillo DJ, et al. Randomized comparison of sirolimus-eluting stent versus standard stent for percutaneous coronary revascularization in diabetic patients: The diabetes and sirolimus-eluting stent (DIABETES) trial. Circulation 2005;112:2175-83. (Pubitemid 41475813)
78. Serruys P. What have we learned from ARTS I and ARTS II? [Special session]. American Heart Association Scientific Sessions 2007. Orlando, November 4 to 7, 2007.
79. Serruys PW, Colombo A, Morice MC, et al. Arterial revascularisation therapies study part II - sirolimus-eluting stents for the treatment of patients with multivessel de novo coronary artery lesions. EuroIntervention 2005;1:147-56.
80. Rodriguez AE, Maree AO, Mieres J, et al. Late loss of early benefit from drug-eluting stents when compared with bare-metal stents and coronary artery bypass surgery: 3 years follow-up of the ERACI III registry. Eur Heart J 2007;28:2118-25. (Pubitemid 47517450)
81. Yang JH, Gwon H-C, Cho SJ, et al. Comparison of coronary artery bypass grafting with drug-eluting stent implantation for the treatment of multivessel coronary artery disease. Ann Thorac Surg 2008;85:65-70. (Pubitemid 350265787)
82. Javaid A, Steinberg DH, Buch AN, et al. Outcomes of coronary artery bypass grafting versus percutaneous coronary intervention with drug-eluting stents for patients with multivessel coronary artery disease. Circulation 2007;116:I-200-I-206.
83. Yang ZK, Shen WF, Zhang RY, et al. Coronary artery bypass surgery versus percutaneous coronary intervention with drug eluting stent implantation in patients with multivessel coronary disease. J Interv Cardiol 2007;20:10-6. (Pubitemid 46164753)
84. Briguori C, Condorelli G, Airoldi F, et al. Comparison of coronary drug-eluting stents versus coronary artery bypass grafting in patients with diabetes mellitus. Am J Cardiol 2007;99:779-84. (Pubitemid 46365594)
85. Lee MS, Jamal F, Kedia G, et al. Comparison of bypass surgery with drug eluting stents for diabetic patients with multivessel disease. Int J Cardiol 2007;123:34-42. (Pubitemid 350119876)
86. Hannan EL, Wu C, Walford G, et al. Drug-eluting stents versus coronary-artery bypass grafting in multivessel coronary disease. New Engl J Med 2008;358:331-41. (Pubitemid 351159232)
87. Kapur A. Coronary artery revascularisation in diabetes. The CARDia trial. [Hot Line II, session 1694-5]. European Society of Cardiology Congress 2008. Munich, August 30 to September 3, 2008.
88. Serruys PW, Morice MC, Kappetein AP, et al; SYNTAX investigators. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. New Engl J Med 2009;360:961-72.
89. Chaitman BR, Hardison RM, Adler D, et al; The Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Study Group. The Bypass Angioplasty Revascularization Investigation 2 Diabetes randomized trial of different treatment strategies in type 2 diabetes mellitus with stable ischemic heart disease: Impact of treatment strategy on cardiac mortality and myocardial infarction. Circulation 2009;120:2529-40.
90. Frye RL, August P, Brooks M, et al; BARI IID Study Group. A randomized trial of therapies for type 2 diabetes and coronary artery disease. N Engl J Med 2009;360:2503-15.
91. Zhao XQ, Brown BG, Stewart DK, et al. Effectiveness of revascularization in the Emory angioplasty versus surgery trial. A randomized comparison of coronary angioplasty with bypass surgery. Circulation 1996;93:1954-62.
92. Bell MR, Gersh BJ, Schaff HV, et al. Effect of completeness of revascularization on long-term outcome of patients with three-vessel disease undergoing coronary artery bypass surgery. A report from the Coronary Artery Surgery Study (CASS) Registry. Circulation 1992;86:446-57.
93. Schaff HV, Rosen AD, Shemin RJ, et al. Clinical and operative characteristics of patients randomized to coronary artery bypass surgery in the Bypass Angioplasty Revascularization Investigation (BARI). Am J Cardiol 1995;75:18C-26C.
94. Gum PA, O'Keefe JH Jr, Borkon AM, et al. Bypass surgery versus coronary angioplasty for revascularization of treated diabetic patients. Circulation 1997;96(9 Suppl):II7-II10.
95. Barsness GW, Peterson ED, Ohman EM, et al. Relationship between diabetes mellitus and long-term survival after coronary bypass and angioplasty. Circulation 1997;96:2551-6. (Pubitemid 27451345)
96. Weintraub WS, Stein B, Kosinski A, et al. Outcome of coronary bypass surgery versus coronary angioplasty in diabetic patients with multivessel coronary artery disease. J Am Coll Cardiol 1998;31:10-9. (Pubitemid 28064716)
97. Kastrati A, Schömig A, Elezi S, Schühlen H, Wilhelm M, Dirschinger J. Interlesion dependence of the risk for restenosis in patients with coronary stent placement in multiple lesions. Circulation 1998;97:2396-401. (Pubitemid 28278182)
98. Barzilay JI, Kronmal RA, Bittner V, Eaker E, Evans C, Foster ED. Coronary artery disease and coronary artery bypass grafting in diabetic patients aged > or = 65 years (report from the Coronary Artery Surgery Study [CASS] Registry). Am J Cardiol 1994;74:334-9.
99. Nahser PJ Jr, Brown RE, Oskarsson H, Winniford MD, Rossen JD. Maximal coronary flow reserve and metabolic coronary vasodilation in patients with diabetes mellitus. Circulation 1995;91:635-40.
100. Farkouh ME, Dangas G, Leon MB, et al. Design of the Future REvascularization Evaluation in patients with Diabetes mellitus: Optimal management of Multivessel disease (FREEDOM) Trial. Am Heart J 2008;155:215-23.